Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Management of incidental adnexal masses

Obstetrics and gynaecology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Incidental does not mean clinically inactive

Severe new pain, vomiting, collapse, peritonism, fever or pregnancy-related symptoms can reveal torsion, rupture, haemorrhage, abscess or ectopic pregnancy around a previously incidental mass.

Action: Move immediately to the relevant acute gynaecology or early-pregnancy pathway, assess ABCDE and pregnancy status, and do not wait for the planned outpatient characterisation scan.

Synopsis

Turn an unexpected adnexal finding into a safe age- and morphology-specific plan, avoiding both unnecessary intervention for low-risk simple cysts and delayed referral of complex or malignant disease.

  • Verify the finding: obtain the original report and images, determine organ of origin, record maximum size and morphology, and establish whether the whole lesion was visible on CT, MRI or ultrasound.
  • Ask about pain, bloating, early satiety, urinary symptoms, bleeding, pregnancy possibility, menopause, endometriosis, fertility treatment, previous cancer and family history before calling a mass asymptomatic.
  • In premenopausal adults, a truly simple cyst smaller than 50 mm generally needs no follow-up; 50–70 mm simple cysts receive yearly ultrasound, while larger lesions merit MRI or surgical assessment.
  • In postmenopausal adults, RCOG's December 2025 update states that an asymptomatic unilateral unilocular simple cyst 3 cm or smaller needs no routine follow-up.
  • A postmenopausal simple unilateral unilocular cyst larger than 3 cm and up to 5 cm with normal CA125 can be reassessed in 4–6 months and discharged after one year if unchanged or smaller with normal CA125.
  • Postmenopausal symptoms, non-simple features, size above 5 cm, multilocularity or bilaterality move the lesion out of the low-risk conservative branch and into surgical or oncology assessment.
  • Use transvaginal ultrasound for definitive morphology when an incidental CT or MRI finding is not already diagnostic; add transabdominal views for large lesions.
  • Assign every observation plan to a named clinician, specify the interval and endpoint, and provide urgent safety-netting rather than writing repeat scan without ownership.

Key red flags

Irregular solid tissue, papillary projections, ascites, metastases, strong vascularity, multilocular-solid morphology or bilateral complex lesions requires urgent specialist malignancy assessment.

Persistent bloating, early satiety, pelvic or abdominal pain, urinary urgency or frequency and unexplained weight loss can make an incidental lesion clinically suspicious, especially after menopause.

Acute unilateral pain with vomiting can be torsion despite a benign earlier report or preserved Doppler flow and needs urgent surgical review.

A positive pregnancy test with pain, bleeding or free fluid requires pregnancy-location assessment rather than routine cyst surveillance.

A complex mass in a patient under 40 needs germ-cell marker assessment and specialist triage; a normal CA125 alone is not reassuring.

Investigation priorities

01
Original-image and report reviewFirst step

Verify organ of origin, dimensions, morphology, temporal comparison and whether the entire lesion was visualised.

Management branches

Finding verificationConvert an incidental phrase into morphology

CT, MRI or non-specialist ultrasound reports an unexpected adnexal lesion.

  1. Retrieve the report and images, compare prior studies and confirm size, laterality, menopausal status, symptoms and pregnancy possibility.
  2. Arrange expert transvaginal ultrasound with transabdominal supplementation unless the existing study already provides adequate definitive characterisation.
  3. Route acute symptoms immediately and assign the non-acute result to a named clinician who will communicate the plan.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • RCOG Green-top Guideline 34: Ovarian Cysts in Postmenopausal Women
  • RCOG Green-top Guideline 62: Ovarian Masses in Premenopausal Women
  • NICE CG122: Ovarian cancer recognition and initial management
  • NHSGGC: Postmenopausal ovarian pathology

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom